A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Public ClinicalTrials.gov record NCT02708095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as baricitinib in participants with systemic lupus erythematosus.
Study identification
- NCT ID
- NCT02708095
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 314 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2016
- Primary completion
- Oct 11, 2017
- Completion
- Nov 8, 2017
- Last update posted
- Nov 20, 2018
2016 – 2017
United States locations
- U.S. sites
- 27
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | — |
| Wallace Rheumatic Study Center | Beverly Hills | California | 90211 | — |
| Medvin Clinical Research | Covina | California | 91723 | — |
| TriWest Research Assocaites | El Cajon | California | 92020 | — |
| University of California | La Jolla | California | 92037 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Inlande Rheumatology Clinical Trials | Upland | California | 91786 | — |
| Denver Arthritis Center | Denver | Colorado | 80230 | — |
| New Horizon Research Center | Miami | Florida | 33175 | — |
| West Broward Rheumatology Associates, Inc | Tamarac | Florida | 33321 | — |
| Clinical Research of West Florida, Inc. | Tampa | Florida | 33603 | — |
| Kansas City Internal Medicine Research | Overland Park | Kansas | 66209 | — |
| The Arthritis & Diabetes Clinic Inc. | Monroe | Louisiana | 71203 | — |
| Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Clayton Medical Research | St Louis | Missouri | 63117 | — |
| Arthritis Consultants | St Louis | Missouri | 63141 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| North Shore University Hospital at Great Neck | Great Neck | New York | 11021 | — |
| The Ohio State University | Columbus | Ohio | 43203 | — |
| Paramount Medical Research | Middleburg Heights | Ohio | 44130 | — |
| Arthritis & Rheumatology Center of Oklahoma PLLC | Oklahoma City | Oklahoma | 73103 | — |
| Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | 73104-5046 | — |
| The Oklahoma Center For Arthritis Therapy | Tulsa | Oklahoma | 74104 | — |
| East Penn Rheumatology | Bethlehem | Pennsylvania | 18015 | — |
| Clinical Research Center of Reading, LLC | Wyomissing | Pennsylvania | 19610 | — |
| Accent Clinical Research Professionals, LLC | Allen | Texas | 75013 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02708095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02708095 live on ClinicalTrials.gov.